Preliminary study on hepatotoxicity induced by dioscin and its possible mechanism.
- Author:
Ya-xin ZHANG
;
Yu-guang WANG
;
Zeng-chun MA
;
Xiang-lin TANG
;
Qian-de LIANG
;
Hong-ling TAN
;
Cheng-rong XIAO
;
Yong-hong ZHAO
;
Yue GAO
- Publication Type:Journal Article
- MeSH:
Cell Survival;
drug effects;
Chemical and Drug Induced Liver Injury;
etiology;
Cytochrome P-450 CYP1A1;
genetics;
Diosgenin;
analogs & derivatives;
toxicity;
Hep G2 Cells;
Humans;
L-Lactate Dehydrogenase;
secretion;
RNA, Messenger;
analysis;
Reactive Oxygen Species;
metabolism;
Receptors, Aryl Hydrocarbon;
genetics
- From:
China Journal of Chinese Materia Medica
2015;40(14):2748-2752
- CountryChina
- Language:Chinese
-
Abstract:
Dioscin has a wide range of biological effects and broad application prospects. However the studies concerning the toxicology and mechanism of dioscin is small. This article is to study the hepatotoxicity of dioscin and the effect of dioscin treatment on expression of aryl hydrocarbon receptor (AhR) mRNA and CYP1A mRNA and protein in HepG2 cells in vitro. Dioscin 0.5-32 µmol · L(-1) exposed to HepG2 cells for 12 h, cell viability was examined by CCK-8 assay and the release rate of lactate dehydrogenase (LDH) was to evaluate cell membrane damage. HepG2 cells morphologic changes were quantified by inverted Microscope, and the effect on production of reactive oxygen species (ROS) was detected by flow cytometry. The mRNA expression of CYP1A and AhR was evaluated by RT-RCR. The protein expression of CYP1A1 was detected by western blot. The cell viability was significantly inhibited after HepG2 cells were exposed to dioscin 0.5-32 µmol · L(-1). Compared with the control, the LDH release rate and ROS were significantly increased. The expression of CYPlA and AhR mRNA was increased. The expression of CYP1Al protein was increased after dioscin treatment, and resveratrol, an AhR antagonist, could downregulate the expression of CYP1A1. It follows that large doses dioscin has potential hepatotoxicity. The possible mechanism may be dioscin can active aryl hydrocarbon receptor (AhR) and induce the expression of CYP1A.
